131 related articles for article (PubMed ID: 29273275)
1. Modulatory effect of voriconazole on the production of proinflammatory cytokines in experimental cryptococcosis in mice with severe combined immunodeficiency.
Gonçalves Silva E; Marilia de Souza Silva S; Rodrigues Paula C; da Silva Ruiz L; Latercia Tranches Dias A
J Mycol Med; 2018 Mar; 28(1):106-111. PubMed ID: 29273275
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).
Silva EG; Paula CR; de Assis Baroni F; Gambale W
Mycopathologia; 2012 Jun; 173(5-6):445-9. PubMed ID: 22071662
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation.
Fujioka K; Nagai T; Kinoshita Y; Urushihara M; Hamasaki Y; Shishido S; Kagami S
CEN Case Rep; 2019 Nov; 8(4):261-265. PubMed ID: 31161376
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
Nishikawa H; Fukuda Y; Mitsuyama J; Tashiro M; Tanaka A; Takazono T; Saijo T; Yamamoto K; Nakamura S; Imamura Y; Miyazaki T; Kakeya H; Yamamoto Y; Yanagihara K; Mukae H; Kohno S; Izumikawa K
J Antimicrob Chemother; 2017 Jun; 72(6):1709-1713. PubMed ID: 28201509
[TBL] [Abstract][Full Text] [Related]
5. Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans.
Silva EG; Paula CR; Dias AL; Chang MR; Ruiz Lda S; Gambale V; Prates RA; Ribeiro MS
Mycopathologia; 2011 Apr; 171(4):261-6. PubMed ID: 20972836
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
Schwarz P; Dromer F; Lortholary O; Dannaoui E
Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection.
Serena C; Pastor FJ; Mariné M; Rodríguez MM; Guarro J
J Antimicrob Chemother; 2007 Jul; 60(1):162-5. PubMed ID: 17483143
[TBL] [Abstract][Full Text] [Related]
8. Combined antifungal therapy against systemic murine infections by rare Cryptococcus species.
Thomson P; Mayayo E; López-Fernández L; Guarro J; Capilla J
Mycoses; 2017 Feb; 60(2):112-117. PubMed ID: 27696562
[TBL] [Abstract][Full Text] [Related]
9. Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans.
Fries BC; Cook E; Wang X; Casadevall A
Antimicrob Agents Chemother; 2005 Jan; 49(1):350-7. PubMed ID: 15616315
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulator tuftsin increases the susceptibility of Cryptococcus neoformans to liposomal amphotericin B in immunocompetent BALB/c mice.
Khan MA; Owais M
J Drug Target; 2005 Aug; 13(7):423-9. PubMed ID: 16308211
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine reduces amphotericin B deoxycholate nephrotoxicity and improves the outcome of murine cryptococcosis.
Magalhães TFF; Costa MC; Holanda RA; Ferreira GF; Carvalho VSD; Freitas GJC; Ribeiro NQ; Emídio ECP; Carmo PHF; de Brito CB; de Souza DG; Rocha CEV; Paixão TA; de Resende-Stoianoff MA; Santos DA
Med Mycol; 2020 Aug; 58(6):835-844. PubMed ID: 31919505
[TBL] [Abstract][Full Text] [Related]
12. Current approach to the acute management of cryptococcal infections.
Powderly WG
J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
[No Abstract] [Full Text] [Related]
13. Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis.
Gazzoni AF; Capilla J; Mayayo E; Guarro J
Int J Antimicrob Agents; 2012 Mar; 39(3):223-7. PubMed ID: 22226648
[TBL] [Abstract][Full Text] [Related]
14. The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis.
Block ER; Bennett JE
Proc Soc Exp Biol Med; 1973 Feb; 142(2):476-80. PubMed ID: 4570039
[No Abstract] [Full Text] [Related]
15. Therapy of experimental meningeal and disseminated cryptococcosis.
Van Cutsem J
Mycoses; 1993; 36(11-12):357-67. PubMed ID: 7935566
[TBL] [Abstract][Full Text] [Related]
16. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
Chang WN; Huang CR; Lei CB; Lee PY; Chien CC; Chang HW; Chang CS; Lu CH
Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
Bava AJ; Negroni R
Eur J Epidemiol; 1992 May; 8(3):422-6. PubMed ID: 1327864
[TBL] [Abstract][Full Text] [Related]
18. Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii.
Mitchell DH; Sorrell TC
Clin Infect Dis; 1992 May; 14(5):1142-4. PubMed ID: 1600018
[TBL] [Abstract][Full Text] [Related]
19. Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.
Barchiesi F; Spreghini E; Schimizzi AM; Maracci M; Giannini D; Carle F; Scalise G
Antimicrob Agents Chemother; 2004 Sep; 48(9):3312-6. PubMed ID: 15328090
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental murine cryptococcosis: a comparison of miconazole and amphotericin B.
Graybill JR; Mitchell L; Levine HB
Antimicrob Agents Chemother; 1978 Feb; 13(2):277-83. PubMed ID: 348099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
